Laser surgery for laryngeal cancer

Laser surgery for laryngeal cancer has a history of more than 30 years. In some developed countries, laser surgery for laryngeal cancer has accounted for 30% to 50% of all laryngeal cancer surgeries, and has a growing trend year by year.

The 5-year survival rate of laser treatment for early laryngeal cancer is 85% to 100%, and its laryngeal function preservation rate is better than that of partial laryngectomy. With the improvement of equipment and technology, the scope of surgical indications has been continuously expanded, from initially limited to the treatment of early glottic laryngeal cancer to today's laser surgery for mid-to-late stage glottic and supraglottic laryngeal cancer.

Laser surgery is increasingly being used in the treatment of early laryngeal cancer. CO2 laser surgery for laryngeal cancer has been widely reported abroad. It has only been gradually developed in China in recent years. The combination of CO2 laser surgical equipment, surgical microscope, and supported laryngoscope for laryngeal surgery has the advantages of no incision in the neck, high surgical accuracy, small surgical damage, fast postoperative recovery, good preservation of laryngeal function, shortened hospital stay, and reduced the economic burden on patients. In other words, patients can retain the functions of speaking, breathing, and pronunciation after surgery. Because tracheotomy is generally not required. Patients only need to be hospitalized for about 1 week, which not only reduces the patient's pain, but also greatly shortens the patient's hospital stay, and also reduces the patient's economic burden. CO2 laser micro-laryngeal surgery under supported laryngoscope can make the surgery of early laryngeal cancer meet the minimally invasive surgery standards required by today's clinical medicine, and has achieved good results in clinical practice.